T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
16/10/26	₩2,030.00	+4.26%	103,221
15/10/26	₩1,947.00	-5.02%	276,888
14/10/26	₩2,050.00	0.00%	106,945
13/10/26	₩2,050.00	-0.73%	262,742

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 16/10/2026			5-day change	1st Jan Change
2,030.00 ^KRW	+4.26%		-7.73%	-48.08%

01-21	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
23/09/24	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI

Market Cap	96.75B 72.57M 64.51M 59.79M 54.4M 103M 6.89B 104M 719M 282M 3.59B 272M 267M 11.46B	P/E 2024	-12.2x	P/E 2025	-3.91x
Enterprise Value	118B 88.85M 78.98M 73.2M 66.6M 126M 8.43B 128M 880M 345M 4.4B 333M 326M 14.03B	EV / Sales 2024	25.1x	EV / Sales 2025	7.45x
Free-Float	85.08%	Yield 2024 *	-	Yield 2025	-

01-21	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
23/09/24	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI
05/08/24	T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment	CI
23/07/24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor	CI
04/07/24	T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
25/06/24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
22/12/23	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
14/12/23	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
18/10/23	CJ Foods Partners with T&R Biofab to Shape the Future of Food	CI
04/08/23	T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	CI
26/07/23	T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	CI
15/05/23	T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
20/09/21	T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	CI

1 day	+4.26%
1 week	-7.73%
Current month	-4.69%
1 month	-10.77%
3 months	-2.40%
6 months	-39.04%
Current year	-48.08%

T&R Biofab Co., Ltd. Stock

Stocks

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Valuation: T&R Biofab Co., Ltd.

Chart: T&R Biofab Co., Ltd.

Latest news: T&R Biofab Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: T&R Biofab Co., Ltd.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

1 week	1,918	2,090
1 month	1,918	2,380
Current year	1,777	4,800
1 year	1,127	4,925
3 years	1,127	9,250
5 years	1,127	29,625
10 years	1,127	37,916.67

Manager	Title	Age	Since
Won-Soo Yoon CEO	Chief Executive Officer	56	-
Young-Pil Kim DFI	Director of Finance/CFO	53	-
Ju-Sung Sim COO	Chief Operating Officer	57	-

Director	Title	Age	Since
Won-Soo Yoon BRD	Director/Board Member	56	-
Jin-Hyung Shin BRD	Director/Board Member	41	-
Song-Wan Jin BRD	Director/Board Member	51	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/6/25 A	Marinho Paulo Andre Nobrega	Others		3,392	0.0157%
3/6/25 A	Eun-kyung Cho	Others		15,492	0.0719%
2/26/25 A	Won-Soo Yoon	Buy	Chief Executive Officer	2,100	0.0097%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
T&R BIOFAB CO., LTD.	+4.26%	-7.73%	+34.96%	-77.21%	72.57M
ABBOTT LABORATORIES	+0.20%	+5.31%	-18.40%	+9.76%	181B
MEDTRONIC PLC	-0.73%	+7.09%	-1.08%	+30.33%	116B
STRYKER CORPORATION	+0.49%	+6.25%	-21.30%	+9.06%	113B
ESSILORLUXOTTICA	+3.83%	+5.50%	-50.59%	-5.64%	79.83B
CENCORA, INC.	-0.14%	+5.27%	+5.00%	+79.86%	65.06B
HOYA CORPORATION	-2.48%	+2.37%	+15.85%	+67.26%	54.35B
BECTON, DICKINSON AND COMPANY	-1.04%	+4.35%	+1.40%	-26.08%	52.23B
IDEXX LABORATORIES, INC.	+2.41%	+8.18%	-11.81%	+31.75%	44.15B
DEXCOM, INC.	-1.90%	+2.29%	+29.19%	+2.28%	32.47B
Average	+1.02%	+4.59%	-1.68%	+12.14%	73.87B
Weighted average by Cap.	+0.60%	+5.59%	-11.13%	+20.07%

	2024	2025
Net sales	4.87B 3.66M 3.25M 3.01M 2.74M 5.17M 347M 5.25M 36.2M 14.19M 181M 13.72M 13.43M 577M	26.97B 20.23M 17.98M 16.66M 15.16M 28.61M 1.92B 29.07M 200M 78.54M 1B 75.91M 74.3M 3.19B
Net income	-7.68B -5.76M -5.12M -4.75M -4.32M -8.15M -547M -8.28M -57.04M -22.36M -285M -21.62M -21.16M -909M	-31.95B -23.97M -21.3M -19.74M -17.96M -33.9M -2.27B -34.44M -237M -93.05M -1.19B -89.94M -88.03M -3.78B
Net Debt	28.78B 21.59M 19.19M 17.79M 16.18M 30.54M 2.05B 31.02M 214M 83.82M 1.07B 81.02M 79.29M 3.41B	21.7B 16.28M 14.47M 13.41M 12.2M 23.03M 1.54B 23.39M 161M 63.2M 806M 61.09M 59.79M 2.57B